Neuropeptide S alters anxiety, but not depression-like behaviour in Flinders Sensitive Line rats: A genetic animal model of depression

International Journal of Neuropsychopharmacology

Volumn 15, Issue 3, 2012, Pages 375-387

  Wegener, Gregers ^a   Finger, Beate C ^b,d   Elfving, Betina ^a   Keller, Kirsten ^a   Liebenberg, Nico ^a   Fischer, Christina W ^a   Singewald, Nicolas ^c   Slattery, David A ^d   Neumann, Inga D ^d   Mathé, Aleksander A ^e  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d UNIVERSITY OF REGENSBURG   (Germany)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Animal model; anxiety; depression; gene expression; NPS

Indexed keywords

NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE S; NEUROPEPTIDE S RECEPTOR; UNCLASSIFIED DRUG; ANXIOLYTIC AGENT; NEUROPEPTIDE; NEUROPEPTIDE S RECEPTOR, RAT; NEUROPEPTIDE S, RAT;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; FLINDERS RESISTANT LINE; FLINDERS SENSITIVE LINE; FORCED SWIMMING TEST; HIPPOCAMPUS; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; MALE; MENTAL DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SPRAGUE DAWLEY RAT; ANIMAL; ANXIETY DISORDERS; BRAIN; DEPRESSIVE DISORDER; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; EXPLORATORY BEHAVIOR; GENETIC PREDISPOSITION; INBRED RAT STRAIN; MAZE TEST; METABOLISM; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; SEXUAL DEVELOPMENT; SPECIES DIFFERENCE; SWIMMING;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; BRAIN; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; MALE; MAZE LEARNING; MOTOR ACTIVITY; NEUROPEPTIDES; NEUROPSYCHOLOGICAL TESTS; RATS, INBRED STRAINS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE; SEX CHARACTERISTICS; SPECIES SPECIFICITY; SWIMMING;

EID: 84858771354     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711000678     Document Type: Article

References (69)

1. Airan RD, Meltzer LA, Roy M, Gong Y, et al. (2007). High-speed imaging reveals neurophysiological links to behavior in an animal model of depression. Science 317, 819-823. (Pubitemid 47257922)
2. Alonso J, Petukhova M, Vilagut G, Chatterji S, et al. (2010). Days out of role due to common physical and mental conditions : results from the WHO World Mental Health surveys. Molecular Psychiatry. Published online : 12 October 2010. doi :10.1038/mp.2010.101.
3. Andersen CL, Jensen JL, Orntoft TF (2004). Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Research 64, 5245-5250. (Pubitemid 39006544)
4. Barros HM, Ferigolo M (1998). Ethopharmacology of imipramine in the forced-swimming test : gender differences. Neuroscience and Biobehavioral Reviews 23, 279-286. (Pubitemid 29011630)
5. Beck B, Fernette B, Stricker-Krongrad A (2005). Peptide S is a novel potent inhibitor of voluntary and fast-induced food intake in rats. Biochemical and Biophysical Research Communications 332, 859-865. (Pubitemid 40745192)
6. Bonefeld BE, Elfving B, Wegener G (2008). Reference genes for normalization : A study of rat brain tissue. Synapse 62, 302-309. (Pubitemid 351365003)
7. Boules M, Shaw A, Fredrickson P, Richelson E (2007). Neurotensin agonists : potential in the treatment of schizophrenia. CNS Drugs 21, 13-23. (Pubitemid 46072347)
8. Braw Y, Malkesman O, Dagan M, Bercovich A, et al. (2006). Anxiety-like behaviors in pre-pubertal rats of the Flinders Sensitive Line (FSL) and Wistar-Kyoto (WKY) animal models of depression. Behavioural Brain Research 167, 261-269. (Pubitemid 43099788)
9. Bunck M, Czibere L, Horvath C, Graf C, et al. (2009). A hypomorphic vasopressin allele prevents anxiety-related behavior. PLoS One 4, e5129.
10. Chiou LC, Liao YY, Fan PC, Kuo PH, et al. (2007). Nociceptin/orphanin FQ peptide receptors : Pharmacology and clinical implications. Current Drug Targets 8, 117-135.
11. Cryan JF, Markou A, Lucki I (2002). Assessing antidepressant activity in rodents: recent developments and future needs. Trends in Pharmacological Sciences 23, 238-245. (Pubitemid 34465544)
12. Domschke K, Reif A, Weber H, Richter J, et al. (2010). Neuropeptide S receptor gene-converging evidence for a role in panic disorder. Molecular Psychiatry. Published online : 6 July 2010. doi:10.1038/mp.2010.81.
13. Donner J, Haapakoski R, Ezer S, Melen E, et al. (2010). Assessment of the neuropeptide S system in anxiety disorders. Biological Psychiatry 68, 474-483.
14. Duangdao DM, Clark SD, Okamura N, Reinscheid RK (2009). Behavioral phenotyping of neuropeptide S receptor knockout mice. Behavioural Brain Research 205, 1-9.
15. El Khoury A, Gruber SH, Mork A, Mathé AA (2006). Adult life behavioral consequences of early maternal separation are alleviated by escitalopram treatment in a rat model of depression. Progress in Neurobiology and Biological Psychiatry 30, 535-540.
16. Elfving B, Bonefeld BE, Rosenberg R, Wegener G (2008). Differential expression of synaptic vesicle proteins after repeated electroconvulsive seizures in rat frontal cortex and hippocampus. Synapse 62, 662-670. (Pubitemid 352032541)
17. Elfving B, Plougmann PH, Muller HK, Mathé AA, et al. (2010). Inverse correlation of brain and blood BDNF levels in a genetic rat model of depression. International Journal of Neuropsychopharmacology 13, 563-572.
18. Fossati P, Amar G, Raoux N, Ergis AM, et al. (1999). Executive functioning and verbal memory in young patients with unipolar depression and schizophrenia. Psychiatry Research 89, 171-187. (Pubitemid 30053000)
19. Fossati P, Coyette F, Ergis AM, Allilaire JF (2002). Influence of age and executive functioning on verbal memory of inpatients with depression. Journal of Affective Disorders 68, 261-271. (Pubitemid 34628333)
20. Frank E, Landgraf R (2008). The vasopressin system-from antidiuresis to psychopathology. European Journal of Pharmacology 583, 226-242.
21. Guerrini R, Salvadori S, Rizzi A, Regoli D, et al. (2009). Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor. Medicinal Research Reviews 30, 751-777.
22. Gupte J, Cutler G, Chen JL, Tian H (2004). Elucidation of signaling properties of vasopressin receptor-related receptor 1 by using the chimeric receptor approach. Proceedings of the National Academy of Sciences USA 101, 1508-1513. (Pubitemid 38234185)
23. Harvey PO, Le Bastard G, Pochon JB, Levy R, et al. (2004). Executive functions and updating of the contents of working memory in unipolar depression. Journal of Psychiatric Research 38, 567-576. (Pubitemid 39348888)
24. Jimenez-Vasquez PA, Diaz-Cabiale Z, Caberlotto L, Bellido I, et al. (2007). Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depression. European Neuropsychopharmacology 17, 298-308. (Pubitemid 46135933)
25. Jimenez Vasquez PA, Salmi P, Ahlenius S, Mathé AA (2000). Neuropeptide Y in brains of the Flinders Sensitive Line rat, a model of depression. Effects of electroconvulsive stimuli and d-amphetamine on peptide concentrations and locomotion. Behavioural Brain Research 111, 115-123. (Pubitemid 30326708)
26. Judd LL, Kessler RC, Paulus MP, Zeller PV, et al. (1998). Comorbidity as a fundamental feature of generalized anxiety disorders : results from the National Comorbidity Study (NCS). Acta Psychiatrica Scandinavica (Suppl.) 393, 6-11. (Pubitemid 28428186)
27. Jungling K, Seidenbecher T, Sosulina L, Lesting J, et al. (2008). Neuropeptide S-mediated control of fear expression and extinction : role of intercalated GABAergic neurons in the amygdala. Neuron 59, 298-310. (Pubitemid 352033690)
28. Kinkead B, Nemeroff CB (2006). Novel treatments schizophrenia : targeting the neurotensin system. CNS and Neurological Disorders-Drug Targets 5, 205-218. (Pubitemid 43803124)
29. Kokras N, Antoniou K, Dalla C, Bekris S, et al. (2009). Sex-related differential response to clomipramine treatment in a rat model of depression. Journal of Psychopharmacology 23, 945-956.
30. Lee AL, Ogle WO, Sapolsky RM (2002). Stress and depression: possible links to neuron death in the hippocampus. Bipolar Disorders 4, 117-128. (Pubitemid 34411274)
31. Leonard SK, Dwyer JM, Sukoff Rizzo SJ, Platt B, et al. (2008). Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders. Psychopharmacology (Berlin) 197, 601-611.
32. Leonard SK, Ring RH (2011). Immunohistochemical localization of the neuropeptide S receptor in the rat central nervous system. Neuroscience 172, 153-163.
33. Li W, Chang M, Peng YL, Gao YH, et al. (2009). Neuropeptide S produces antinociceptive effects at the supraspinal level in mice. Regulatory Peptides 156, 90-95.
34. Liebenberg N, Wegener G, Harvey BH, Brink CB (2010). Investigating the role of protein kinase-G in the antidepressant-like response of sildenafil in combination with muscarinic acetylcholine receptor antagonism. Behavioural Brain Research 209, 137-141.
35. Mathé AA, Biederbeck DI, Gruber S, El Khoury A, et al. (2006) Neuropetide Y, calcitonin gene-related peptide and CRH in brain of rats bred for high anxiety-related behaviors. American College of Neuropsychopharmacology (ACNP), 45th Annual Meeting (pp. 51-52). Hollywood, Florida : American College of Neuropsychopharmacology (ACNP).
36. Mathé AA, Husum H, El Khoury A, Jimenez-Vasquez P, et al. (2007). Search for biological correlates of depression and mechanisms of action of antidepressant treatment modalities. Do neuropeptides play a role? Physiology & Behavior 92, 226-231. (Pubitemid 47374236)
37. Meis S, Bergado-Acosta JR, Yanagawa Y, Obata K, et al. (2008). Identification of a neuropeptide S responsive circuitry shaping amygdala activity via the endopiriform nucleus. PLoS One 3, e2695.
38. Mori M, Hayashi K, Miya H, Sato S, et al. (2002). Novel polypeptide; DNA thereof and use of the same. Patent application : PCT/JP2002/009446.
39. Mourlon V, Baudin A, Blanc O, Lauber A, et al. (2010). Maternal deprivation induces depressive-like behaviours only in female rats. Behavioural Brain Research 213, 278-287.
40. Neumann ID, Wegener G, Homberg JR, Cohen H, et al. (2010). Animal models of depression and anxiety : what do they tell us about human condition? Progress in Neuro-Psychopharmacology and Biological Psychiatry. Published online : 1 December 2010. doi:10.1016/j.pnpbp.2010.11.028.
41. Nielsen DM (2006). Corticotropin-releasing factor type-1 receptor antagonists : the next class of antidepressants? Life Sciences 78, 909-919. (Pubitemid 43112527)
42. Overstreet DH, Friedman E, Mathé AA, Yadid G (2005). The Flinders Sensitive Line rat : A selectively bred putative animal model of depression. Neuroscience & Biobehavioral Reviews 29, 739-759. (Pubitemid 40762598)
43. Overstreet DH, Pucilowski O, Rezvani AH, Janowsky DS (1995). Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. Psychopharmacology (Berlin) 121, 27-37.
44. Paxinos G, Watson C (1986). The Rat Brain in Stereotaxic Coordinates. Sydney: Academic.
45. Porsolt RD, Anton G, Blavet N, Jalfre M (1978). Behavioural despair in rats : A new model sensitive to antidepressant treatments. European Journal of Pharmacology 47, 379-391.
46. Porsolt RD, Bertin A, Jalfre M (1977). Behavioral despair in mice: A primary screening test for antidepressants. Archives Internationales de Pharmacodynamie et de Therapie 229, 327-336. (Pubitemid 8225714)
47. Pulkkinen V, Majuri ML, Wang G, Holopainen P, et al. (2006). Neuropeptide S and G protein-coupled receptor 154 modulate macrophage immune responses. Human Molecular Genetics 15, 1667-1679. (Pubitemid 43904833)
48. Raczka KA, Gartmann N, Mechias ML, Reif A, et al. (2010). A neuropeptide S receptor variant associated with overinterpretation of fear reactions : A potential neurogenetic basis for catastrophizing. Molecular Psychiatry 15, 1067-1074.
49. Reinscheid RK (2007). Phylogenetic appearance of neuropeptide S precursor proteins in tetrapods. Peptides 28, 830-837. (Pubitemid 46349337)
50. Reinscheid RK, Xu YL, Okamura N, Zeng J, et al. (2005). Pharmacological characterization of human and murine neuropeptide s receptor variants. Journal of Pharmacology and Experimental Therapeutics 315, 1338-1345. (Pubitemid 41635423)
51. Ring RH (2005). The central vasopressinergic system: examining the opportunities for psychiatric drug development. Current Pharmaceutical Design 11, 205-225. (Pubitemid 40089841)
52. Rizzi A, Vergura R, Marzola G, Ruzza C, et al. (2008). Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice. British Journal of Pharmacology 154, 471-479. (Pubitemid 351670609)
53. Schiller GD, Daws LC, Overstreet DH, Orbach J (1991). Lack of anxiety in an animal model of depression with cholinergic supersensitivity. Brain Research Bulletin 26, 433-435.
54. Slattery DA, Desrayaud S, Cryan JF (2005). GABAB receptor antagonist-mediated antidepressant-like behavior is serotonin-dependent. Journal of Pharmacology and Experimental Therapeutics 312, 290-296. (Pubitemid 40096480)
55. Slattery DA, Finger BC, Malumby R, Wegener G, et al. (2008). Neuropeptide S alters affective behaviour in high (HAB) but not low anxiety-related (LAB) rats. Washington, D. C. : Society for Neuroscience.
56. Smith KL, Patterson M, Dhillo WS, Patel SR, et al. (2006). Neuropeptide S stimulates the hypothalamo-pituitaryadrenal axis and inhibits food intake. Endocrinology 147, 3510-3518. (Pubitemid 43901142)
57. Valdez GR (2006). Development of CRF1 receptor antagonists as antidepressants and anxiolytics : progress to date. CNS Drugs 20, 887-896. (Pubitemid 44611138)
58. Varty GB, Cohen-Williams ME, Hunter JC (2003). The antidepressant-like effects of neurokinin NK1 receptor antagonists in a gerbil tail suspension test. Behavioural Pharmacology 14, 87-95. (Pubitemid 36279029)
59. Vendelin J, Pulkkinen V, Rehn M, Pirskanen A, et al. (2005). Characterization of GPRA, a novel G protein-coupled receptor related to asthma. American Journal of Respiratory Cell and Molecular Biology 33, 262-270. (Pubitemid 41254293)
60. Videbech P, Ravnkilde B (2004). Hippocampal volume and depression: A meta-analysis of MRI studies. American Journal of Psychiatry 161, 1957-1966. (Pubitemid 39441394)
61. Vitale G, Filaferro M, Ruggieri V, Pennella S, et al. (2008). Anxiolytic-like effect of neuropeptide S in the rat defensive burying. Peptides 29, 2286-2291. (Pubitemid 50287237)
62. Walf AA, Frye CA (2007). The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nature Protocols 2, 322-328. (Pubitemid 47040046)
63. Wegener G, Finger BC, Slattery DA, Neumann ID, et al. (2008). Neuropeptide S alters depression-and anxiety-like behaviors in the Flinders Sensitive Line rats, a genetic animal model of depression. Washington, DC: Society for Neuroscience.
64. Wegener G, Harvey BH, Bonefeld B, Muller HK, et al. (2010). Increased stress-evoked nitric oxide signalling in the Flinders sensitive line (FSL) rat : A genetic animal model of depression. International Journal of Neuropsychopharmacology 13, 461-473.
65. Wegener G, Mathé AA, Neumann ID (in press). Selectively bred rodents as models of depression and anxiety. In : Cryan, J, Reif, A (Eds), Behavioral Neurogenetics. Springer Verlag. WHO (2004). The global burden of disease : 2004 update. WHO Reports.
66. Wittchen HU, Zhao S, Kessler RC, Eaton WW (1994). DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Archives of General Psychiatry 51, 355-364. (Pubitemid 24176813)
67. Xu YL, Gall CM, Jackson VR, Civelli O, et al. (2007). Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain. Journal of Comparative Neurology 500, 84-102. (Pubitemid 44904303)
68. Xu YL, Reinscheid RK, Huitron-Resendiz S, Clark SD, et al. (2004). Neuropeptide S: A neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43, 487-497. (Pubitemid 39094676)
69. Yadid G, Nakash R, Deri I, Tamar G, et al. (2000). Elucidation of the neurobiology of depression: insights from a novel genetic animal model. Progress in Neurobiology 62, 353-378. (Pubitemid 30336473)